Highlight Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3

- Investments
-
189
- Portfolio
-
116
- Exits
-
38

Highlight Capital General Information
Description
Founded in 2014, Highlight Capital is a venture capital firm based in Shanghai, China. The firm seeks to invest in the healthcare services, biomedicine, medical technology, mobile healthcare, and pharmaceutical sectors.
Contact Information
Website
www.hlc.com.cn
Year Founded
2014
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
- Fengyang Road No.659, 3F
- Jingan District
- Shanghai, Shanghai
- China
+86 021 0000 0000
Highlight Capital Investments (189)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Probio Technology | 23-Jan-2023 | Later Stage VC | 00000 | Biotechnology | Generating Revenue | |
000000000 000000 | 18-Jan-2023 | 00000 00000 | 00000 | BPO/Outsource Services | Generating Revenue | |
0000 000000000000 | 16-Jan-2023 | 00000 00000 | Biotechnology | Generating Revenue | ||
0000000 0000000000 | 02-Dec-2022 | 00000 00000 | General Purpose Semiconductors | Generating Revenue | ||
000000000 0000000 | 01-Nov-2022 | 00000 00000 | Surgical Devices | Profitable | ||
000000 0000000 | 01-Oct-2022 | 00000 00000 | Medical Supplies | Generating Revenue | ||
00000 0000000 | 28-Sep-2022 | 00000 00000 | Biotechnology | Generating Revenue | ||
000000 00000000000 | 19-Sep-2022 | 00000 00000 | Application Specific Semiconductors | Startup | ||
AllianThera Biopharma | 18-Jun-2022 | Early Stage VC | Drug Discovery | Generating Revenue | ||
Béaba | 01-Jun-2022 | PE Growth/Expansion | Other Consumer Durables | Profitable |
Highlight Capital Exits (38)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Gaush Medical | 30-Nov-2022 | IPO | 000.00 |
00000000 | 26-Aug-2022 | 000000000 00000000 | |
000000-0000000 | 22-Aug-2022 | 000 | 00.000 |
0000000 0000000000 | 25-Jul-2022 | 000 00 00000000 | |
00000000000 | 05-Oct-2021 | 000000000000000000 | |
00000 00000000000 | 09-Jul-2021 | 000 | 00000 |
000000 000 0000 00 | 07-Jul-2021 | 000 | 00000 |
00000 0000000 0000 | 05-Jul-2021 | 000 | 00000 |
Baheal Pharmaceutical Group | 30-Jun-2021 | IPO | 000.00 |
Nayuki | 30-Jun-2021 | IPO | 00000 |
Highlight Capital Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Highlight Capital Investments by Industry, Year, and Region
Highlight Capital Team (3)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Hui Wang Ph.D | Founding Partner & Managing Partner | 0 | 0 | Shanghai, China |
Highlight Capital Co-Investors (266)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Legend Capital | 8 | 0 |
![]() |
![]() |
|
Sequoia Capital China | 0 | 0 |
![]() |
![]() |
|
Hillhouse Capital Group | 0 | 0 |
![]() |
![]() |
|
Addor Capital | 0 | 0 |
![]() |
![]() |
|
Lake Bleu Capital | 0 |
![]() |
![]() |